1. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Issue 33 (7th August 2015) Authors: Luabeya, Angelique Kany Kany; Kagina, Benjamin M.N.; Tameris, Michele D.; Geldenhuys, Hennie; Hoff, Soren T.; Shi, Zhongkai; Kromann, Ingrid; Hatherill, Mark; Mahomed, Hassan; Hanekom, Willem A.; Andersen, Peter; Scriba, Thomas J.; H56-032 Trial Study Group, 1; Schoeman, Elisma; Krohn, Colleen; D... Journal: Vaccine Issue: Volume 33:Issue 33(2015) Page Start: 4130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults. Issue 33 (7th August 2015) Authors: Luabeya, Angelique Kany Kany; Kagina, Benjamin M.N.; Tameris, Michele D.; Geldenhuys, Hennie; Hoff, Soren T.; Shi, Zhongkai; Kromann, Ingrid; Hatherill, Mark; Mahomed, Hassan; Hanekom, Willem A.; Andersen, Peter; Scriba, Thomas J.; Schoeman, Elisma; Krohn, Colleen; Day, Cheryl L.; Africa, Hadn; M... Journal: Vaccine Issue: Volume 33:Issue 33(2015) Page Start: 4130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗